Acetylserotonin O-methyltransferase

From WikiMD's WELLNESSPEDIA

Enzyme involved in the biosynthesis of melatonin

Acetylserotonin O-methyltransferase

Acetylserotonin O-methyltransferase (ASMT), also known as hydroxyindole O-methyltransferase (HIOMT), is an enzyme that plays a crucial role in the biosynthesis of melatonin, a hormone that regulates circadian rhythms and sleep-wake cycles in humans and other animals.

Function[edit]

ASMT catalyzes the final step in the synthesis of melatonin from serotonin. Specifically, it transfers a methyl group from S-adenosyl methionine (SAM) to N-acetylserotonin, converting it into melatonin. This reaction is essential for the production of melatonin in the pineal gland, particularly during the night when melatonin synthesis is at its peak.

Structure[edit]

ASMT is a member of the methyltransferase family of enzymes. It is characterized by a conserved SAM-dependent methyltransferase domain, which is responsible for binding SAM and facilitating the transfer of the methyl group. The enzyme's structure allows it to specifically recognize and bind to its substrate, N-acetylserotonin, ensuring the precise conversion to melatonin.

Regulation[edit]

The activity of ASMT is regulated by various factors, including the availability of its substrates, SAM and N-acetylserotonin, and the expression of the ASMT gene. The enzyme's activity is also influenced by circadian clock genes, which help synchronize melatonin production with the day-night cycle.

Clinical Significance[edit]

Alterations in ASMT activity can affect melatonin levels, potentially leading to sleep disorders and other circadian rhythm-related issues. Research has also suggested a link between ASMT gene polymorphisms and certain psychiatric disorders, such as autism spectrum disorder and bipolar disorder.

Related Enzymes[edit]

ASMT is part of a broader pathway involving several other enzymes, including:

Related pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.